RECENT FUNDING
  1. Recent Funding
  2. Companies
  3. Ankyra Therapeutics

Ankyra Therapeutics

Ankyra is developing cancer therapies based on localized cytokines that prime a systemic adaptive immune response.

Latest funding

Series B+ ·

Amount not disclosed in a source on record.

Funding history ↓
Website: ankyratx.com.
X: @ankyratx · 40 followers.
LinkedIn: linkedin.com.
Category: Health and bio.
Sectors: Biotechnology, Oncology.
Stage: Series B+.
Based in: Boston, United States.
Last round: Oct 2, 2024 · 775 days ago.
On Recent Funding since: Nov 8, 2026.

Signals

X account@ankyratx · created Feb 17, 2022 (4 years old) · 40 followers
Website registeredNov 21, 2019 (7 years old)

Funding rounds

DateRoundAmountLeadSource
Series B+undisclosed—fundraisingfox.com

Timeline

  1. X account created
  2. Website created

Founders and team

Investors

Companies like Ankyra Therapeutics

Sources and API

Every amount links to the page it came from. * Estimated from an accelerator's published standard deal, not a company-specific disclosure. How Recent Funding sources and verifies funding data. The same data as JSON: /api/v1/companies/ankyra-therapeutics (get a free API key).

Top raises, every week

The week's top funded startups and market insights, in your inbox every Monday.

Unsubscribe anytime · privacy